THERAPY IN DIABETES EDUCATION. WHERE ARE WE?

被引：0
|
作者：
Isla Pera, Pilar [1 ]
机构：
[1] Univ Barcelona, Dept Enfermeria Salud Publ Salud Mental & Materno, EUE, Barcelona, Spain
来源：
REVISTA ROL DE ENFERMERIA | 2011年 / 34卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Patients with diabetes mellitus (DM) who receive no education cannot make informed decisions to maintain acceptable metabolic control, increasing the likelihood of complications [1]. Education and prevention of diabetes mellitus (DM) are the central theme of World Diabetes Day during the period 2009/ 2013. The key messages of this campaign advocating: 1) Know the risks of DM and its warning signs, 2) Know what to do and who to call and 3) Learn how to manage and control. Education is the primary theme of this campaign promoted by the International Diabetes Federation (IDF) and the World Health Organization (WHO) [1].
引用
收藏
页码：432 / 438
页数：7
相关论文
共 50 条
  • [31] Cardiovascular Disease in Children and Adolescents with Diabetes: Where Are We, and Where Are We Going?
    Truong, Uyen T.
    Maahs, David M.
    Daniels, Stephen R.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 : S11 - S21
  • [32] Molecular Targets for Endometriosis Therapy: Where We Are and Where We Are Going?
    Barra, Fabio
    Lagana, Antonio Simone
    Casarin, Jvan
    Ghezzi, Fabio
    Desideri, Lorenzo Ferro
    Scala, Carolina
    Ferrero, Simone
    [J]. INTERNATIONAL JOURNAL OF FERTILITY & STERILITY, 2019, 13 (02) : 89 - 92
  • [33] Cellular therapy in multiple sclerosis: where we are and where we are going
    G. Martino
    [J]. Neurological Sciences, 2005, 26 : s21 - s21
  • [34] Targeted therapy for cancer: where we are today and where we are heading
    Melville, Graeme
    [J]. FUTURE ONCOLOGY, 2015, 11 (22) : 3065 - 3067
  • [35] Gene therapy - where are we?
    Smith, AE
    [J]. LANCET, 1999, 354 : SI1 - SI4
  • [36] Immunotherapy of Type 1 Diabetes: Where Are We and Where Should We Be Going?
    Luo, Xunrong
    Herold, Kevan C.
    Miller, Stephen D.
    [J]. IMMUNITY, 2010, 32 (04) : 488 - 499
  • [37] Targeting therapy in pemphigus: Where are we now and where are we going?
    Abulikemu, Kailibinuer
    Hu, Fengxia
    Liang, Junqin
    Kang, Xiaojing
    [J]. HELIYON, 2023, 9 (06)
  • [38] Cellular therapy in multiple sclerosis: where we are and where we are going
    Martino, G
    [J]. NEUROLOGICAL SCIENCES, 2005, 26 (Suppl 1) : S21 - S21
  • [39] Statin therapy: Where are we? Where do we go next?
    Gotto, AM
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (5A): : 13B - 18B
  • [40] Blood Flow Restriction Therapy: Where We Are and Where We Are Going
    Vopat, Bryan G.
    Vopat, Lisa M.
    Bechtold, Megan M.
    Hodge, Kevin A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2020, 28 (12) : E493 - E500
12345